Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
JLABS
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
(-) Other news
Partner news
Press release

Period

2019

Jan
Mar
Apr
Jun
(-) Jul
Aug
Oct
Dec

Locations & regions

EMEA

Focus area

Pharmaceuticals

Clear filters

News

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story

Sidebar

Currently trending

Currently trending

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine
Driving Innovation In UK Life Sciences
Vor Biopharma Closes $110 Million Series B Financing
CVRx Raises $50 Million in New Equity Financing
Investing in innovation – new digital approaches for a new decade
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs
As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on
HistoSonics Announces $40 Million Financing

Trending

Trending

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

Johnson & Johnson Innovation, Change One Thing, Change Everything: Medopad

Johnson & Johnson Innovation, Change One Thing, Change Everything: Exonate